Long-term Follow-up Study of AL-001 Ophthalmic Injection in Subjects with WAMD

A Long-term Follow-up Study to Evaluate the Safety and Effectivity of AL-001 Ophthalmic Injection in Subjects with Wet Age-related Mecular Degeneration (wAMD)

This study is designed to evaluate long-term safety and efficacy of AL-001 ophthalmic injection following suprachoroidal space(SCS) administration in subjects with wAMD. Eligible patients, are those who were previously enrolled in a clinical study in which they received a single dose of AL-001 administered via suprachoroidal space injection.

Inclusion Criteria:

• The subjects enrolled in AL-001 study and received AL-001 ophthalmic injection.
• The subject or their legal representative agrees to participate in this study and signs a written ICF.
• The subjects are willing and able to follow planned visits and procedures.

Exclusion Criteria:

• None